logo
Select company
Select metric
$ 4.26MEarning Before Interest & Taxes (EBIT)
VS
Market
43
Sector
79
Industry
91
History
100
$ 12.4Close
$ 6.3 - $ 178.5 52-Week Range
Ticker Information

Ticker

BCTX

Company Name

BRIACELL THERAPEUTICS CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BRIACELL THERAPEUTICS CORP - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BCTX - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
3/31/2025$ 4.26M
12/31/2024$ 1.13M
9/30/2024$ -2.31M
6/30/2024$ -4.93M
3/31/2024$ -20.8M
12/31/2023$ -17.23M
9/30/2023$ -11.87M
6/30/2023$ -23.27M
3/31/2023$ -18.02M
12/31/2022$ -16.07M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BRIACELL THERAPEUTICS CORP's latest trailing twelve months (TTM) EBIT stands at $ -3.78M.
  • Over the past 5 years, BRIACELL THERAPEUTICS CORP's average EBIT has been $ -9.44M.
  • The median EBIT for BRIACELL THERAPEUTICS CORP during this period was $ -11.12M
  • BRIACELL THERAPEUTICS CORP reached its highest EBIT over the past 5 years at $ 4.26M.
  • The lowest EBIT recorded by BRIACELL THERAPEUTICS CORP in the same timeframe $ -23.27M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

BCTX - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -23.27M

Minimum

Jun 30, 2023

$ 4.26M

Maximum

Mar 31, 2025

$ -9.44M

Average

$ -11.12M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M